Posted inLondon Stock Exchange
GSK has acquired 35Pharma Inc for $950 million
LONDON: GSK plc (LSE/NYSE: GSK) today announced the completion of its acquisition of 35Pharma Inc., a Canada-based, private, clinical-stage biopharmaceutical company specialising in the development of novel protein-based therapeutics. The acquisition…